Impaired prenatal and postnatal growth in Dutch patients with phenylketonuria. The National PKU Steering Committee.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Archives of Disease in Childhood

• Publication date

  1994-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/adc.71.2.114PMID 7944529PMCID PMC1029938
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• SMOCC: Design of a Representative Cohort-study of Live-born Infants in the Netherlands

  1992cited by this paper
• Prevalence of congenital heart disease in patients with phenylketonuria.

  1991cited by this paper
• Physical growth of children treated for phenylketonuria.

  1991cited by this paper
• [Are earlier birth weights different from current ones?].

  1990cited by this paper
• [15 years of national screening for phenylketonuria in The Netherlands; 4th Report of the National Commission for Management of Phenylketonuria].

  1990cited by this paper
• The Metabolic basis of inherited disease

  1989cited by this paper
• [Disease course in 20 patients with an early diagnosis of phenylketonuria and hyperphenylalaninemia].

  1988cited by this paper
• [10 years' national screening study of the incidence of phenylketonuria in the Netherlands; 3d report of the National Advisory Phenylketonuria Commission].

  1985cited by this paper
• [10 years' national screening study of the incidence of phenylketonuria in the Netherlands; 3d report of the National Advisory Phenylketonuria Commission].

  1985cited by this paper
• Plasma phenylalanine and tyrosine levels during the day in normal female controls and female obligate phenylketonuria heterozygotes.

  1982cited by this paper
• Excess weight among children with phenylketonuria.

  1982cited by this paper
• Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies.

  1980cited by this paper
• Physical growth in phenylketonuria: II. Growth of treated children in the PKU collaborative study from birth to 4 years of age.

  1979cited by this paper
• Physical growth in phenylketonuria: I. A retrospective study.

  1979cited by this paper
• Birthweight of infants with phenylketonuria and their unaffected siblings

  1978cited by this paper
• Birthweight of children with phenylketonuria.

  1976cited by this paper
• Natural history of phenylketonuria and influence of early treatment.

  1974cited by this paper
• Birthweights in children with phenylketonuria and in their siblings.

  1972cited by this paper
• [Intrauterine growth and intrauterine growth curves].

  1969cited by this paper
• Head circumference from birth to eighteen years. Practical composite international and interracial graphs.

  1968cited by this paper
• Adequacy of low-phenylalanine diet.

  1967cited by this paper
• Phenylalanine deficiency syndrome.

  1966cited by this paper
• Elevation of plasma phenylalanine levels during pregnancies of women heterozygous for phenylketonuria

  1963cited by this paper
• The metabolic basis of inherited disease

  1961cited by this paper

• Total Head Growth in Patients with Phenylketonuria Diagnosed by Newborn Screening Test

  2025cites this paper
• Phenotypic study of humanized mice carrying the PAH deep intronic variant c.1199+502A>T

  2025cites this paper
• Nutritional status in patients with protein metabolism disorders. Case-control study.

  2024cites this paper
• Evaluating Therapy and Growth in Children with Phenylketonuria: A Retrospective Longitudinal Study from Two Romanian Centers

  2024influential citation
• Estado nutricional en errores innatos del metabolismo de las proteínas. Estudio caso-control

  2024cites this paper
• The BMI Z-Score and Protein Energy Ratio in Early- and Late-Diagnosed PKU Patients from a Single Reference Center in Mexico

  2023cites this paper
• Allelic phenotype prediction of phenylketonuria based on the machine learning method

  2023cites this paper
• Recommendations on phenylketonuria in Turkey.

  2022cites this paper
• Long‐term anthropometric development of individuals with inherited metabolic diseases identified by newborn screening

  2022cites this paper
• Glycomacropeptide in PKU—Does It Live Up to Its Potential?

  2022cites this paper
• Phenylketonuria

  2021cites this paper
• Assessment of Anthropometric Indices in Patients with Phenylketonuria

  2020cites this paper
• Overweight in classical phenylketonuria children: A retrospective cohort study.

  2019cites this paper
• Growth, Protein and Energy Intake in Children with PKU Taking a Weaning Protein Substitute in the First Two Years of Life: A Case-Control Study

  2019cites this paper
• Long-Term Growth in Phenylketonuria: A Systematic Review and Meta-Analysis

  2019influential citation
• Normal Growth in PKU Patients Under Low-Protein Diet in a Single-Center Cross-Sectional Study.

  2019cites this paper
• Vitamin/mineral and micronutrient status in patients with classical phenylketonuria.

  2018cites this paper
• Growth and Final Height Among Children With Phenylketonuria

  2017cites this paper
• The complete European guidelines on phenylketonuria: diagnosis and treatment

  2017cites this paper
• Phenylketonuria Treatment’s Impact on Physical Growth: A Spanish Retrospective Longitudinal Study

  2016cites this paper
• Evaluation of Physical Growth and Weight Patterns of Egyptian Children with Phenylketonuria under a Phenylalanine-Restricted Diet

  2016cites this paper
• New insights in growth of phenylketonuric patients

  2015cites this paper
• Protein Requirements in Inherited Metabolic Diseases

  2015cites this paper
• Phenylketonuria Treatment's Impact on Physical Growth:

  2015cites this paper
• Phenylketonuria TreatmentsImpact on Physical Growth:A Spanish RetrospectiveLongitudinal Study

  2015cites this paper
• Nutrient intake and body composition in children with phenylketonuria

  2015cites this paper
• Development of an innovative strategy based on engineered autologous erythrocytes as “enzyme replacement therapy” for the treatment of Phenylketonuria

  2015cites this paper
• New ways of defining protein and energy relationships in inborn errors of metabolism.

  2014cites this paper
• Anthropometric characteristics and nutrition in a cohort of PAH-deficient patients.

  2014cites this paper
• Is overweight an issue in phenylketonuria?

  2013cites this paper
• Early dietary treated patients with phenylketonuria can achieve normal growth and body composition.

  2013cites this paper
• Molecular Genetics and Metabolism

  2013cites this paper
• Weaning infants with phenylketonuria: a review.

  2012cites this paper
• Optimising growth in phenylketonuria: current state of the clinical evidence base.

  2012cites this paper
• Physical development in patients with phenylketonuria on dietary treatment: a retrospective study.

  2011cites this paper
• Nutrition in phenylketonuria.

  2011cites this paper
• Phenylalanine hydroxylase deficiency

  2011cites this paper
• Increased palmitoyl-myristoyl-phosphatidylcholine in neonatal rat surfactant is lung specific and correlates with oral myristic acid supply.

  2011cites this paper
• Mild hyperphenylalaninemia: to treat or not to treat

  2011cites this paper
• Follow up of phenylketonuria patients.

  2011cites this paper
• Mild hyperphenylalaninemia: to treat or not to treat

  2011cites this paper
• A long-term study of bone mineral density in patients with phenylketonuria under diet therapy

  2011cites this paper
• Fatty acid profile in patients with phenylketonuria and its relationship with bone mineral density

  2010cites this paper
• Whole body composition analysis by the BodPod air-displacement plethysmography method in children with phenylketonuria shows a higher body fat percentage

  2010cites this paper
• Recommendations for protein and energy intakes by patients with phenylketonuria

  2009cites this paper
• Comparison of the protein quality of dietetically treated phenylketonuria patients with the recommendations of the WHO expert consultation

  2009cites this paper
• Phenylketonuria: Dietary and therapeutic challenges

  2007cites this paper
• Growth and body composition in children with classical phenylketonuria: Results in 34 patients and review of the literature

  2007cites this paper
• Dietary treatment in PKU from experience to evidence

  2007cites this paper
• Morbidity from excessive intake of high energy fluids: the 'squash drinking syndrome'

  2006cites this paper
• The intake of total protein, natural protein and protein substitute and growth of height and head circumference in Dutch infants with phenylketonuria

  2005influential citation
• Inherited metabolic diseases and pregnancy

  2005cites this paper
• Protein substitutes for PKU: What's new?

  2004cites this paper
• A different approach to breast-feeding of the infant with phenylketonuria

  2003cites this paper
• Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria

  2003cites this paper
• Nutrient intakes and physical growth of children with phenylketonuria undergoing nutrition therapy.

  2003cites this paper
• Elevated plasma phenylalanine concentrations may adversely affect bone status of phenylketonuric mice

  2002cites this paper
• Growth parameters in newborns with hyperphenylalaninaemia.

  2002cites this paper
• Hyperphenylalaninemia and birth weight.

  2002cites this paper
• Borstvoeding: ook voor het kind met fenylketonurie

  2002cites this paper
• Protein insufficiency and linear growth restriction in phenylketonuria.

  2002cites this paper
• Diet and compliance in phenylketonuria

  2000cites this paper
• Nutrition, physical growth, and bone density in treated phenylketonuria

  2000cites this paper
• Nutrient intake and growth of infants with phenylketonuria undergoing therapy.

  1998cites this paper
• Donor pretreatment with ambroxol or dexamethasone fails to ameliorate reperfusion injury in experimental lung transplantation

  1998cites this paper
• Does a single plasma phenylalanine predict quality of control in phenylketonuria?

  1998cites this paper
• Reduction in birth weight in phenylketonuria.

  1997cites this paper
• Does impaired growth of PKU patients correlate with the strictness of dietary treatment?

  1997cites this paper
• Body protein in prepubertal children with phenylketonuria.

  1996cites this paper
• Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria.

  1996cites this paper
• Measurement of pulmonary status and surfactant protein levels during dexamethasone treatment of neonatal respiratory distress syndrome.

  1996cites this paper
• Evidence for a superantigen mediated process in Kawasaki disease.

  1995cites this paper
• Physical growth in patients with phenylketonuria

  1995cites this paper
• No reduction in birth weight in phenylketonuria

  1995cites this paper
• Birth weight in phenylketonuria.

  1995cites this paper
• Burkholderia cepacia and delta F508 homozygosity in cystic fibrosis.

  1995cites this paper
• Growth in patients with phenylketonuria

  1994cites this paper